miércoles, 7 de octubre de 2026
BuscarExplore
es.VIA.NEWS
Source trace. Via News points to the documents behind its reporting and shows what we drew from each — so you can check any claim. How we source
Source document· February 15, 2026

'Everyone Thinks Trump Is Our Friend—He's Not': Mark Yusko Exposes Crypto Reality

View original at finance.yahoo.com
'Everyone Thinks Trump Is Our Friend—He's Not': Mark Yusko Exposes Crypto Reality Benzinga and Yahoo Finance LLC may earn commission or revenue on some items through the links below…
Opening lines of the source · short snapshot — read the full document at the original

Lo que extrajimos de esta fuente

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • Bitcoin only reached $126,000 versus fair value around $90,000—just 35% above fair value versus 2x in prior cycles, meaning less upside and less downside

    80% confidence

  • Treasury Secretary Scott Bessent and others are working with Cantor Fitzgerald and Tether on clandestine initiatives to preserve dollar hegemony and prevent China's yuan from becoming world reserve currency

    80% confidence

  • Bitcoin targets $63,000 as bottom

    80% confidence

  • The four-year Bitcoin cycle (actually 3 years 11 months based on Bitcoin blocks) stays intact with trough arriving around September 30-October 1, 2026

    80% confidence

  • A short squeeze is coming that will drive Bitcoin prices higher, similar to what drove gold from $2,000 to $5,000

    80% confidence

  • If gold settles at $30 trillion market cap and Bitcoin achieves gold equivalence at $15 trillion, that reaches $750,000 per Bitcoin at 10x current levels

    80% confidence

  • Brian Armstrong was labeled public enemy number one by Wall Street for fighting the Clarity Act

    80% confidence

  • Bitcoin bottoms around $58,000-$63,000 in September 2026

    80% confidence

  • President Trump has a whole different agenda for crypto focused on preserving dollar dominance, not helping crypto

    80% confidence

  • Ethereum has better odds than competitors despite higher costs and slower speeds because it has more developers, more activity, and more infrastructure already built

    80% confidence

  • The current version of the Clarity Act is a non-starter that takes crypto down the path of CBDCs, centralization, and control

    80% confidence

  • Institutions like Millennium buy Bitcoin ETFs but short futures to remain market neutral, suppressing prices

    80% confidence

  • Previous Bitcoin cycles saw falls of 84% and 75% from peaks

    80% confidence

  • Bitcoin will reach $600,000-$700,000 by September 2029

    80% confidence

  • JP Morgan made $20 billion from gold market spoofing while only paying $960 million in fines, treating it as cost of doing business

    80% confidence
Lo que sabemos · la inteligencia detrás de esta página
En vivo desde el sustrato
Lo que estamos viendo
Autumn 2026 Biopharma Catalyst Season: Late-Breaking Data, FDA Milestones and the Rise of AI-Designed Drugs
Late-September and early-October 2026 conferences (EASD, EADV, IGCS) brought a cluster of positive late-breaking trial readouts. These covered obesity and metabolic disease (Novo Nordisk's CagriSema), immunology (Lilly's EBGLYSS, tulisokibart) and oncology (Rina-S, Agenus BOT+BAL). Ahead lie hard regulatory catalysts, led by the 14 Nov 2026 FDA PDUFA date for ivonescimab. At the same time, Insilico-style AI-designed drugs such as rentosertib are showing anti-aging signals. That points to AI-driven drug discovery moving from concept toward clinical validation. Unrelated tech and regulatory items (Tesla Cybercab probe, xAI litigation, OpenAI agent incident) and the speculative QAIAx claims are peripheral to this story.
Nuestra lectura de los datos ›
Señales que seguimos
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patrones que observamos ›
Donde las fuentes discrepan
ING Group
Both facts record the same metric (shares_outstanding) for ING Group at the identical observation date (2025-12-31). FACT A states 2,902,437,688 shares; FACT B states 2,902 million shares (2,902,000,000). The difference is 437,688 shares (~0.015%). This is a genuine value conflict, though the discrepancy appears to result from FACT B rounding to the nearest million while FACT A provides the precise count.
Señalamos los conflictos abiertamente ›
Verificado recientemente
✓ Verificado con la fuente original
4,986
hechos rastreados a su fuente — y señalamos los que no se sostienen.
101 entidades seguidas4,986 hechos verificados con la fuente5,362 documentos fuente archivados
Consulta estos datos → isubstrate.com
'Everyone Thinks Trump Is Our Friend—He's Not': Mark Yusko Exposes Crypto Reality — Source | Via News | es.VIA.NEWS